526 related articles for article (PubMed ID: 31340755)
21. Non-contrast liver MRI as an alternative to gadoxetic acid-enhanced MRI for liver metastasis from colorectal cancer.
Hwang JA; Kim YK; Min JH; Song KD; Sohn I; Ahn HS
Acta Radiol; 2019 Apr; 60(4):441-450. PubMed ID: 30130970
[TBL] [Abstract][Full Text] [Related]
22. Prospective comparison of gadoxetic acid-enhanced liver MRI and contrast-enhanced CT with histopathological correlation for preoperative detection of colorectal liver metastases following chemotherapy and potential impact on surgical plan.
Jhaveri KS; Fischer SE; Hosseini-Nik H; Sreeharsha B; Menezes RJ; Gallinger S; Moulton CE
HPB (Oxford); 2017 Nov; 19(11):992-1000. PubMed ID: 28760631
[TBL] [Abstract][Full Text] [Related]
23. Performance of gadoxetic acid-enhanced MRI for detecting hepatocellular carcinoma in recipients of living-related-liver-transplantation: comparison with dynamic multidetector row computed tomography and angiography-assisted computed tomography.
Kakihara D; Nishie A; Harada N; Shirabe K; Tajima T; Asayama Y; Ishigami K; Nakayama T; Takayama Y; Okamoto D; Fujita N; Kishimoto J; Honda H
J Magn Reson Imaging; 2014 Nov; 40(5):1112-20. PubMed ID: 24259437
[TBL] [Abstract][Full Text] [Related]
24. Added Value of a Gadoxetic Acid-enhanced Hepatocyte-phase Image to the LI-RADS System for Diagnosing Hepatocellular Carcinoma.
Chen N; Motosugi U; Morisaka H; Ichikawa S; Sano K; Ichikawa T; Matsuda M; Fujii H; Onishi H
Magn Reson Med Sci; 2016; 15(1):49-59. PubMed ID: 26104079
[TBL] [Abstract][Full Text] [Related]
25. Combined gadoxetic acid and gadofosveset enhanced liver MRI for detection and characterization of liver metastases.
Bannas P; Bookwalter CA; Ziemlewicz T; Motosugi U; Munoz Del Rio A; Potretzke TA; Nagle SK; Reeder SB
Eur Radiol; 2017 Jan; 27(1):32-40. PubMed ID: 27137648
[TBL] [Abstract][Full Text] [Related]
26. Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases.
Shin NY; Kim MJ; Lim JS; Park MS; Chung YE; Choi JY; Kim KW; Park YN
Eur Radiol; 2012 Apr; 22(4):864-71. PubMed ID: 22108766
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic efficacy of gadoxetic acid-enhanced MRI for the detection and characterisation of liver metastases: comparison with multidetector-row CT.
Kim YK; Park G; Kim CS; Yu HC; Han YM
Br J Radiol; 2012 May; 85(1013):539-47. PubMed ID: 22556405
[TBL] [Abstract][Full Text] [Related]
28. Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases.
Donati OF; Fischer MA; Chuck N; Hunziker R; Weishaupt D; Reiner CS
Eur J Radiol; 2013 May; 82(5):822-8. PubMed ID: 23287713
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.
Chan VO; Das JP; Gerstenmaier JF; Geoghegan J; Gibney RG; Collins CD; Skehan SJ; Malone DE
Ir J Med Sci; 2012 Dec; 181(4):499-509. PubMed ID: 22426901
[TBL] [Abstract][Full Text] [Related]
30. Preoperative detection of colorectal liver metastases: DWI alone or combined with MDCT is no substitute for Gd-EOB-DTPA-enhanced MRI.
Schulz A; Joelsen-Hatlehol ES; Brudvik KW; Aasand KK; Hanekamp B; Viktil E; Johansen CK; Dormagen JB
Acta Radiol; 2020 Mar; 61(3):302-311. PubMed ID: 31335157
[No Abstract] [Full Text] [Related]
31. One-stop-shop preoperative evaluation for living liver donors with gadoxetic acid disodium-enhanced magnetic resonance imaging: efficiency and additional benefit.
Xie S; Liu C; Yu Z; Ren T; Hou J; Chen L; Huang L; Cheng Y; Ji Q; Yin J; Zhang L; Shen W
Clin Transplant; 2015 Dec; 29(12):1164-72. PubMed ID: 26448564
[TBL] [Abstract][Full Text] [Related]
32. Feasibility of Routine Application of Gadoxetic Acid-Enhanced MRI in Combination with Diffusion-Weighted MRI for the Preoperative Evaluation of Colorectal Liver Metastases.
Tanaka M; Kishi Y; Esaki M; Nara S; Miyake M; Hiraoka N; Nagino M; Shimada K
Ann Surg Oncol; 2016 Nov; 23(12):3991-3998. PubMed ID: 27357179
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.
Semaan S; Vietti Violi N; Lewis S; Chatterji M; Song C; Besa C; Babb JS; Fiel MI; Schwartz M; Thung S; Sirlin CB; Taouli B
Eur Radiol; 2020 Feb; 30(2):1020-1030. PubMed ID: 31673837
[TBL] [Abstract][Full Text] [Related]
34. The role of diffusion-weighted imaging in the detection of hepatic metastases from colorectal cancer: A comparison with unenhanced and Gd-EOB-DTPA enhanced MRI.
Colagrande S; Castellani A; Nardi C; Lorini C; Calistri L; Filippone A
Eur J Radiol; 2016 May; 85(5):1027-34. PubMed ID: 27130067
[TBL] [Abstract][Full Text] [Related]
35. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.
Tateyama A; Fukukura Y; Takumi K; Shindo T; Kumagae Y; Kamimura K; Nakajo M
World J Gastroenterol; 2012 Nov; 18(43):6269-76. PubMed ID: 23180948
[TBL] [Abstract][Full Text] [Related]
36. Liver imaging reporting and data system v2014 categorization of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Comparison with multiphasic multidetector computed tomography.
Joo I; Lee JM; Lee DH; Ahn SJ; Lee ES; Han JK
J Magn Reson Imaging; 2017 Mar; 45(3):731-740. PubMed ID: 27474328
[TBL] [Abstract][Full Text] [Related]
37. Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT.
Inoue T; Kudo M; Komuta M; Hayaishi S; Ueda T; Takita M; Kitai S; Hatanaka K; Yada N; Hagiwara S; Chung H; Sakurai T; Ueshima K; Sakamoto M; Maenishi O; Hyodo T; Okada M; Kumano S; Murakami T
J Gastroenterol; 2012 Sep; 47(9):1036-47. PubMed ID: 22526270
[TBL] [Abstract][Full Text] [Related]
38. Magnetic resonance assessment of sinusoidal obstruction syndrome after neoadjuvant chemotherapy for colorectal liver metastases is not reproducible.
Staal FC; Beets-Tan RG; Heeres BC; Houwers J; de Boer M; van Dorth D; Lambregts DM; Maas M
Acta Radiol; 2021 Sep; 62(9):1133-1141. PubMed ID: 32972213
[TBL] [Abstract][Full Text] [Related]
39. Comparison of contrast-enhanced ultrasonograpy with Gd-EOB-DTPA-enhanced MRI in the diagnosis of liver metastasis from colorectal cancer.
Shiozawa K; Watanabe M; Ikehara T; Matsukiyo Y; Kogame M; Kikuchi Y; Otsuka Y; Kaneko H; Igarashi Y; Sumino Y
J Clin Ultrasound; 2017 Mar; 45(3):138-144. PubMed ID: 27861987
[TBL] [Abstract][Full Text] [Related]
40. Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI?
Kulemann V; Schima W; Tamandl D; Kaczirek K; Gruenberger T; Wrba F; Weber M; Ba-Ssalamah A
Eur J Radiol; 2011 Aug; 79(2):e1-6. PubMed ID: 20392584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]